Articles related to ADVERSE EVENTS
Symmetric Drug-Related Intertriginous and Flexural Exanthema
This case study underlines the importance of recognizing SDRIFE, a distinct drug-induced dermatological reaction, and the pivotal role of a detailed medication history in dermatological diagnosis, ensuring improved patient outcomes.
Dermatology February 22nd 2024
Images in Clinical Medicine: Exogenous Ochronosis from Skin-Lightening Cream
A recent case study underscores the potential risks of long-term use of hydroquinone-containing skin-lightening creams, leading to a rare but challenging diagnosis of exogenous ochronosis.
Dermatology January 24th 2024
Minimizing Toxicity in Conference Abstracts May Undermine Cancer Care, Data Suggest
In a recent comprehensive review, 15.2% of oncology conference abstracts used language that minimized treatment toxicities, potentially leading to misinformed treatment plans and impacting patient care. A call to action for clearer, data-driven communication in the field.
Hematology/Oncology January 8th 2024
Long-term Survival Observed in HIMALAYA Study of Durvalumab Plus Tremelimumab for uHCC
Discover how STRIDE is setting new benchmarks in the treatment of unresectable hepatocellular carcinoma, offering both improved survival rates and a tolerable safety profile.
Hepatology October 9th 2023
What We Know About Semaglutide Adverse Events and Gastroparesis: Part I
New reports and studies are raising concerns about the gastrointestinal safety of semaglutide-containing medications; clinicians are advised to exercise caution and monitor patients for symptoms of gastroparesis.
Endocrinology, Diabetes, Metabolism October 4th 2023